Taibang

Centurium considers stake sale in US$6 billion Taibang Biologic: sources
[ad_1] [HONG KONG] Chinese private equity firm Centurium Capital is considering selling its stake in Taibang Biologic Group, people familiar with the matter said. Centurium has been sounding out potential buyers,...